CB Scientific Inc. (OTCMKTS:CBSC) is up 200% in a week. The non-invasive ambulatory cardiac monitoring products and services designer, producer, and distributor have announced successful uplisting to the OTCQB Venture Market from OTC Pink Sheets.
Trading Data
On Wednesday, CBSC stock fell 7% to $0.42 with more than 46K shares traded, compared to its average Wednesday of 15K shares. The stock moved within a range of $0.3900 – 0.4200 after opening trading at $0.39.
CB Scientific, Inc. Announces Uplist to the OTCQB(R) Venture Market
CBSC will now start trading on the OTCQB market from April 6, 2022, under the ticker symbol “CBSC.” CEO of the company Charles Martin said that trading on the OTCQB is a massive milestone for CB Scientific, offering enhanced transparency and increased liquidity for current and prospective stockholders. He added that listing on the OTCQB market will give the company access to a larger investor pool which is critical for the firm this year.
To list on OTCQB, companies should have audited financial statements, be current with their disclosures and undergo yearly authentication and management certification. Equally, a company has to meet the minimum bid requirement and other financial terms. Chairman of the company Paul Danner said achieving this milestone is vital in pursuing CB Scientific’s business objective.
Key Quote
“Trading on OTCQB is an important achievement for our Company, providing increased transparency and improved liquidity to both existing and prospective shareholders,” said Charles Martin, Chief Executive Officer of CB Scientific, Inc. “In combination with plans underway for ongoing corporate growth through the balance of the year, we believe listing on the OTCQB will allow our story to reach a wider investor audience, a key objective for the Company in 2022.”
Technical Data
CBSC stock is trading above the 20-Day and 50-Day Moving averages of $0.2471 and $0.2814 respectively. Moreover, the stock is trading above the 200-Day moving average of $0.3186.
